TITLE

Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A

AUTHOR(S)
Pietrowski, D.; Szabo, L.; Sator, M.; Just, A.; Egarter, C.
PUB. DATE
January 2012
SOURCE
Human Reproduction;Jan2012, Vol. 27 Issue 1, p196
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening condition associated with increased vascular permeability. The vascular endothelial growth factor (VEGF) system and its receptors have been identified as the main angiogenic factors responsible for increased capillary permeability and are therefore discussed as crucial for the occurrence of OHSS. Recently, a number of soluble receptors for the VEGFs have been detected (sVEGF-Rs) and it has been shown that these sVEGF-Rs compete with the membrane-standing VEGF-R to bind VEGFs. METHODS We analyzed the serum levels of soluble VEGF-R1, -R2 and -R3 in 34 patients suffering from OHSS and in 34 controls without this disease. In a subgroup analysis, we correlated the severity of the OHSS with the detected amounts of VEGF-R1, -R2 and -R3. In addition, we determined the amount of total VEGF-A in the samples. RESULTS All the three soluble VEGF receptors tended to be higher in the control group compared with that in the OHSS group but this difference only reached significance for sVEGF-R2 (mean ± SEM: 15.5 ± 0.6 versus 13.8 ± 0.5 ng/ml, respectively, P< 0.05). In the subgroup analysis, sVEGF-R2 levels decreased as the severity of OHSS increased (OHSS-I: 16.8 ± 1.9 ng/ml and OHSS-III: 12.7 ± 1.0 ng/ml, P< 0.05) Moreover, the serum levels of total VEGF-A were higher in the OHSS group than those in the controls (537.7 ± 38.9 versus 351 ± 53.4 pg/ml, respectively P< 0.05). CONCLUSIONS We propose that VEGF-A plays a role in the occurrence of OHSS, that the amount of biologically available VEGF-A is modulated by sVEGF-Rs and that different combinations of VEGF-A and sVEGF-R levels might contribute to the severity of OHSS.
ACCESSION #
69899438

 

Related Articles

  • Ovarian hyperstimulation syndrome. Kumar, Pratap; Sait, Sameer Farouk; Sharma, Alok; Kumar, Mukesh // Journal of Human Reproductive Sciences;May-Aug2011, Vol. 4 Issue 2, p70 

    Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of assisted reproduction technology. The syndrome is characterized by cystic enlargement of the ovaries and a fluid shift from the intravascular to the third space due to increased capillary permeability and ovarian...

  • SELECTED ORAL COMMUNICATION SESSION, SESSION 25: TRANSLATIONAL RESEARCH, Monday 4 July 2011 17:00 – 18:00.  // Human Reproduction;Jan2011 Supplement 1, Vol. 26 Issue suppl_1, pi37 

    No abstract available.

  • Interaction between granulosa-lutein cells and monocytes regulates secretion of angiogenic factors in vitro. Połeć, Anna; Ráki, Melinda; Åbyholm, Thomas; Tanbo, Tom G.; Fedorcsák, Peter // Human Reproduction;Oct2011, Vol. 26 Issue 10, p2819 

    BACKGROUND Leukocyte infiltration and angiogenesis in the forming corpus luteum are prerequisites for normal ovarian function and may also underlie disorders like ovarian hyperstimulation syndrome. We examined whether ovarian angiogenesis could be affected by an interaction between...

  • Alternative angiogenic pathways in melanoma: the role of AQP1. Rao, Stefania; De Biasi, Silvia; Cagnoli, Laura; Clemente, Claudio; Porta, Caterina Am La // Journal of Solid Tumors;Oct2011, Vol. 1 Issue 2, p34 

    AQP1 belongs to aquaporins family, water-specific, membrane-channel proteins expressed preferentially by micro vessels, favoring angiogenesis and increasing permeability. Recently, we have demonstrated that AQPl has a role as bio-mechanic sensor modulating and stabilizing the organization of...

  • Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes. Shoji, Takuhito; Koyama, Hidenori; Morioka, Tomoaki; Tanaka, Shinji; Kizu, Akane; Motoyama, Kohka; Mori, Katsuhito; Fukumoto, Shinya; Shioi, Atsushi; Shimogaito, Noriko; Takeuchi, Masayoshi; Yamamoto, Yasuhiko; Yonekura, Hideto; Yamamoto, Hiroshi; Nishizawa, Yoshiki // Diabetes;Aug2006, Vol. 55 Issue 8, p2245 

    Angiogenic response is impaired in diabetes. Here, we examined the involvement of receptor for advanced glycation end products (RAGE) in diabetes-related impairment of angiogenesis in vivo. Angiogenesis was determined in reconstituted basement membrane protein (matrigel) plugs containing...

  • The effects of ‘coasting’ on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome. Tozer, A. J.; Iles, R. K.; Iammarrone, E.; Gillott, C. M. Y.; Al-Shawaf, T.; Grudzinskas, J. G. // Human Reproduction;Vol. 19 Issue 3, p522 

    BACKGROUND: The aim of this study was to assess the effect of withholding gonadotrophins (coasting) during controlled ovarian stimulation (COS) on individual follicle concentrations of follicular fluid vascular endothelial growth factor (VEGF) in women at high risk of developing ovarian...

  • Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling. Awasthi, Niranjan; Schwarz, Margaret A.; Verma, Varun; Cappiello, Clint; Schwarz, Roderich E. // Laboratory Investigation (00236837);Jan2009, Vol. 89 Issue 1, p38 

    Endothelial monocyte activating polypeptide II (EMAP II) is a proinflammatory cytokine with antiangiogenic properties. EMAP II functions as a potent inhibitor of primary and metastatic tumor growth, has strong inhibitory effects on endothelial cells (ECs), and can reduce intratumoral expression...

  • Ras pathway inhibition prevents neovascularization by repressing endothelial cell sprouting. Westenskow, Peter D.; Kurihara, Toshihide; Aguilar, Edith; Scheppke, Elizabeth L.; Moreno, Stacey K.; Wittgrove, Carli; Marchetti, Valentina; Michael, Iacovos P.; Anand, Sudarshan; Nagy, Andras; Cheresh, David; Friedlander, Martin // Journal of Clinical Investigation;Oct2013, Vol. 123 Issue 10, p1 

    Vascular networks develop from a growing vascular front that responds to VEGF and other guidance cues. Angiogenesis is required for normal tissue function, but, under conditions of stress, inappropriate vascu-larization can lead to disease. Therefore, inhibition of angiogenic sprouting may...

  • EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF. Gordon, L K; Kiyohara, M; Fu, M; Braun, J; Dhawan, P; Chan, A; Goodglick, L; Wadehra, M // Oncogene;11/14/2013, Vol. 32 Issue 46, p5369 

    Understanding tumor-induced angiogenesis is a challenging problem with important consequences for the diagnosis and treatment of cancer. In this study, we define a novel function for epithelial membrane protein-2 (EMP2) in the control of angiogenesis. EMP2 functions as an oncogene in endometrial...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics